Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis

In the present study, the objective was to attain a localized lung delivery of an anti-tubercular fluoroquinolone, moxifloxacin (MXF), targeting the alveolar macrophages through a non-invasive pulmonary route using inhalable microspheres as a dry powder inhaler approach. MXF-loaded poly (lactic-co-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishwa, Bhavya, Moin, Afrasim, Gowda, D. V., Rizvi, Syed M. D., Hegazy, Wael A. H., Abu Lila, Amr S., Khafagy, El-Sayed, Allam, Ahmed N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827815/
https://www.ncbi.nlm.nih.gov/pubmed/33430162
http://dx.doi.org/10.3390/pharmaceutics13010079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827815/
https://www.ncbi.nlm.nih.gov/pubmed/33430162
http://dx.doi.org/10.3390/pharmaceutics13010079

Ejemplares similares